Bulletin - April, 1989 by Civil Aviation Medical Association
Wright State University 
CORE Scholar 
Browse all Civil Aviation Medical Association 
Newsletters 
Civil Aviation Medical Association Records 
(MS-526) 
4-1989 
Bulletin - April, 1989 
Civil Aviation Medical Association 
Follow this and additional works at: https://corescholar.libraries.wright.edu/special_ms526_newsletter 
 Part of the Aviation Safety and Security Commons, and the Medicine and Health Sciences Commons 
Repository Citation 
Civil Aviation Medical Association (1989). Bulletin - April, 1989. . 
This Newsletter is brought to you for free and open access by the Civil Aviation Medical Association Records 
(MS-526) at CORE Scholar. It has been accepted for inclusion in Browse all Civil Aviation Medical Association 
Newsletters by an authorized administrator of CORE Scholar. For more information, please contact library-
corescholar@wright.edu. 
CAVA 
Headquarters 
775 Bank Lane — Room 211 
Lake Forest, Illinois 60045 
phone (312) 234-6330 
B U L L E T I N 
O F T H E 
CIL/IL AVmOH /V IEDIOIL / ISSOCMTION 
APRIL 1989 
President's Message 
By M. Young Stokes, III, M.D. 
ENJOY LONDON THIS SEPTEMBER 
WITH CAMA 
Time is running and very soon September will be with 
us and the CAMA meeting in London will be starting, 
continuing, and finishing. Don't miss this outstanding 
opportunity to visit London, renew your certification as 
an Aviation Medical Examiner by attending the FAA 
Aviation Medicine Seminar which is included. By now 
you should have received the color brochure showing 
parts of the meeting such as travel arrangements, costs, 
etc. Remember the Board of Trustees meeting on the 
afternoon of Sunday, September 17th, followed that 
evening by a grand reception with hot and cold hors 
d'oeuvres and an open bar. Wednesday night will be the 
medieval feast at the Beefeaters (walking distance). 
Friday night will be the final banquet at the hotel and 
Saturday morning will be departure for home. 
The minimum information about all that is included 
with this "package" failed to mention a luncheon on 
Tuesday September 19th and another luncheon and 
also a trip to a medical museum on Thursday, Sep-
tember 21st. After the opening ceremonies on Monday, 
September 18th, most of that day's program will be 
devoted to FAA forms and explanations for NEW AME's. 
This might be time for others to go on tours, such as to 
the Tower of London, just two blocks from the Tower 
Thistle Hotel which is our Headquarters for the meeting, 
or to Windsor Castle, and/or the Doll House, or any of 
numerous short trips available. 
Monday, Tuesday and Thursday nights are open. If 
you want to go to the theater, it will be necessary to get 
tickets very soon. Two popular theater productions at 
that time will be "Phantom of the Opera" and "Les 
Miserables". Our transportation arrangements with 
British Airways will be flexible enough to permit ex-
tensions to visit longer in Britain, or to visit other 
countries, either before or after the CAMA meeting. The 
special airfare from the several USA departure cities 
would NOT permit shortening the trip by coming late or 
leaving early. We have had inquiries about upgrading 
airfare from Tourist to First Class and this IS possible, 
but if credits from other airline travel clubs or plans are 
to be used, this must be cleared with the other lines. 
Mileage credits for this trip on British Airways will be 
accepted by American Airlines, United Airlines, and 
U.S. Air. Perhaps others will also accept the mileage 
credits, but we cannot promise at this time. 
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Welcome Aboard! 
We welcome the following new members into the fellowship of CAMA. 
Frank Anders, M.D. Bill R. Fulk, M.D. Larry C. Sears, M.D. 
P.O. Drawer 630 P.O. Box 1116 302 S. Grand 
Ville Platte, LA 70586 Du Quoin, IL 62832 Gainsville, TX 76240 
Mark Anderson, M.D. Robert J . Goldstone, M.D. John L. Sessions, D.O. 
2390 Redwood Road 2929 University Dr. 1609 S. Margaret 
Salt Lake City, UT 84119 Coral Springs, FL 33065 Kirbyville, TX 75956 
J . R. Becky, M.D. Thomas G. Johnson, M.D. David N. Sim, M.D. 
6750 Stapleton Drive South 311 No. Fourth St. 6014 Emerald St. 
Denver, CO 80216 Oakland, MD 21550 Boise, ID 83704 
Daniel B. Bond, D.O. David B. Kessler, M.D. Robert L. Stokes, M.D. 
290 E. 15th Ave. 7610 Carroll Ave. 3621 Belleview 
Eugene, OR 97401 Takoma Park, MD 20912 Kansas City, MO 64111 
Avrom S. Brown, D.O. James D. Levy, M.D. Lars Tjensvoll, M.D. 
N.E. Medical Center, #15 CMC, Inc. Risalleen 6 B 
Roosevelt Blvd. & Welch Rd. 16 S. Eutaw St. N-0374 Oslo, Norway 
Philadelphia, PA 19114 Baltimore, MD 21201 
Kurt von Maur, M.D. 
J . R. Burgess, M.D. Dr. S.Y. Merali 10653 Sudan 
560 North Park 38 Godfrey Dr. Kalamazoo, Ml 49002 
Helena, MT 59601 Cooper Cliff, Ont. POM 1N0 
Canada John W. Wang, M.D. 
Glen M. Byers, M.D. Route 101-A 
2850 Westside Dr., NW Peter Overgaard, M.C. Amherst, NH 03031 
Cleveland, TN 37311 Box 484 
Lindstrom, MN 44045 Dr. Swan S. Ward 
Sam C. Carter, M.D. 4500 Clearview Parkway 
1722 S. Carolina Vincent S. Parziale, M.D. Metairie, LA 70006 
Harlingen, TX 78550 3803 Spring St., #305 
Racine, Wl 53405 William A. Weathers, M.D. 
Dr. William Chernenkoff 502 Cajon St. 
502 Queen St. Leo F. Rogers, M.D. Redlands, CA 92373 
Saskatoon, Saskatchewan S7K 0M5 3118 Custer Drive 
Canada Lexington, KY 40502 Paul T. Wehman, D.O. 
Box 508 
Leopold Delisle, A.M.C. E.M. Sager, M.D. Council, ID 83612 
350 Brassard Blvd. 7000 Cutler Ave., N.E., #W-8 
St-Paul de Joliette Albuquerque, NM 87110 Joseph R. Wilson, M.D. 
Que. J0K 3E0, Canada 1198 Kenly Ave. 
Glenn D. Schexnayder, M.D. Hagerstown, MD 21740 
John F. Evans, M.D. 214 Clinic Dr. 
P.O. Box 21046 Donaldsonville, LA 70346 
Wichita, K S 67208 
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NEWS OF MEMBERS 
Astronaut Story Musgrave 
• • • • • • • • 
CAMA Past President, Dr. Robert S . Poole, is the 
new American Airl ines Area Medical Director for the 
Eastern Division, headquartered in New York City. 
• • • • • • • • 
Dr. Milton Gordon, our man in Jerusa lem, sends 
Shalom from the Holy Land. At age 77 he is retiring 
after 15 years as Civil Air Surgeon for the State of 
Israel. Milt still lectures at the Flight Surgeon's Sem-
inar for the Israel Air Force, and is a member of the 
Aviation Appeal Board. He looks forward to attending 
the London meeting in September. 
Dr. Story Musgrave, CAMA Life Member and NASA 
Astronaut for 22 years, will make his third journey 
into space this August. The mission, S T S - 3 3 , will be 
on D I S C O V E R Y . Story deployed the first I U S / T D R S 
satellite and performed the first shuttle spacewalk 
during the maiden voyage of Chal lenger in Apri l , 
1983. His second flight, also on Challenger, and 
designated Spacelab #2, was in Ju ly 1985, and in-
volved the operation of an astronomical observatory 
carried in the shuttle cargo bay. 
• • • • • • • • 
After 30 years of service in Papua, New Guinea, 
CAMA member Dr. James (Jim) Jacobi was recently 
honored with a Knighthood by her Majesty, Queen 
Elizabeth II in the New Year's Honours List. Hence-
forth, Dr. Jacobi should be addressed as: Dr. Sir 
James Jacobi, Kt., O B E , M.D. B.S., Phc. 
• • • • • • • • 
Dr. M. Young Stokes III was recently elected a 
director of the Silver Anniversary Fraternity, an organ-
ization of people who have been flying for more than 
25 years. 
• • • • • • • • 
Dr. Robert L. Wick, J r . , CAMA Past President, was 
recently elected Chairman of the Air Transport A s -
sociation Medical Panel, the industry organization for 
the United States Air Carr iers. 
• • • • • • «r * 
Al and Harriett Carr iere have just completed their 
second decade of service, as Secretariat, to the Civil 
Aviation Medical Associat ion. 
• • • • • • • • 
Representatives from 20 countries attended a Reg-
ional Civi l Aviation Medicine Seminar held in Bang-
kok, February 20-24 1989, and sponsored by ICAO. 
The following CAMA members were present: Dr. 
George Takahashi , Ottawa, Canada; Dr. Steve Bl iz-
zard, Nepean, Ontario, Canada; and Dr. Silvio Finkel-
stein, Montreal, Canada. 
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HIDDEN HEART 
D ISEASE 
by 
James A. Sbarbaro, M.D., F.A.C.C 
Many patients with cardivascular abnormalit ies 
present with clear and unequivocal symptomatology. 
Breathlessness, chest pain, palpitations, and syncope 
provide valuable c lues in the search for the underly-
ing etiology of these cardiovascular complaints. How-
ever, in recent years attention has been focused on a 
large group of patients with significant cardiac di-
sease and no symptoms. Within this population are 
many individuals destined to undergo sudden cardiac 
death as the first manifestation of cardiac disease. In 
fact, it has been estimated that as many as 25% of the 
approximately 600,000 people who die suddenly in 
this country every year of cardiac disease have 
sudden death as their first warning of a cardiac 
problem. Accordingly, this monograph will focus 
attention on the most common forms of hidden heart 
disease and methods which the practitioner may 
utilize in screening the asymptomatic population for 
these disorders. 
I believe the easiest way to understand this com-
plex subject is to group patients into two large 
categories of hidden heart disease, congenital and 
acquired. Congenital forms of hidden heart disease 
include congenital abnormalit ies of the coronary 
arteries, the various forms of hypertropic cardiomyop-
athy, Marfan's Syndrome, the Wolff-Parkinson-White 
Syndrome, and the Idiopathic Long Q T Syndrome. 
Congenital abnormalities other than those of the 
coronary arteries will not be d iscussed here as the 
presentation of those entities is usually not silent. 
With regard to acquired forms of hidden heart 
disease, we in essence are dealing with coronary 
artery disease and silent myocardial ischemia. S ince 
it is estimated that silent myocardial ischemia may be 
present in as many as one to two million Americans, 
we will give considerable attention to this problem. 
Coronary artery anomalies (the case of Pete Mar-
avich is a recent reminder) can account for sudden 
death in young people. Anomalies such as a single 
coronary artery, take off of the left main coronary 
artery from the right coronary cusp, and take off of a 
coronary artery from the pulmonary artery are con-
ditions which can cause chronic silent myocardial 
ischemia and sudden death. At autopsy, the heart of 
Pete Maravich was large and fibrotic suggesting 
multiple episodes of myocardial ischemia in the past. 
Detection of these individuals continues to be 
difficult s ince chest pain in young active people is 
often dismissed as musculoskeletal or psychoso-
matic. Clear ly, any young person with a typical 
history of exertional chest pain deserves further 
attention and possibly stress testing. However, in 
many of these individuals symptoms are transient, 
not thought to be important by the patient, and 
therefore unreported. 
Hypertrophic cardiomyopathy, when one excludes 
young individuals who die suddenly of coronary 
atherosclerosis, accounts for the largest percentage 
of young patients dying suddenly. Th is congen ia l ly 
inherited abnormality of cardiac muscle often dispro-
portionately thickens the intraventricular septum, 
although abnormal myocardial cel ls can be present 
in other myocardial locations, or even diffusely. 
Patients often present with fatigue, dyspnea, chest 
pain, or syncope. Any of these complaints, especial ly 
in a patient with a systol ic ejection murmur, should 
prompt further cardiovascular evaluation. Careful 
auscultation, employing the valsalva maneuver, can 
often help determine the etiology of a systolic murmur 
in the young. Palpation of the PMI and carotid artery 
impulse are often helpful in this assessment, with the 
rapid rise in ventricular pressure and mid-systolic dip 
in pressure (with obstruction) giving the character-
istic double apicla or carotid impulse. Echocardio-
graphy is invaluable in further studying these patients 
and is recommended when the cl inical suspicion of 
hypertrophic cardiomyopathy with or without left 
ventricular outflow tract obstruction is present. Treat-
ment include beta blockers, calcium blockers, and in 
rare cases, septal myectomy. However, while symp-
toms may be improved by these maneuvers, the 
incidence of sudden death is not altered. Clearly 
such individuals, if hypertrophic cardiomyopathy is 
documented, should be prohibited from engaging in 
extremely strenuous activity. 
Although patients with typical Marfan's Syndrome 
are easily detected clinically, very often significant 
abnormalit ies of the aortic root and aortic valve may 
be present in patients without the typical physical 
stigmata of this disorder. Once again if there is any 
suggestion that Marfan's Syndrome is present, an 
echocardiogram is invaluable in the further evaluation 
of the patient. The tragic case of Flo Hyman, whose 
sudden death on the volleyball court was a compli-
cation of Marfan's Syndrome, serves to illustrate the 
occasional lethality of this condition. 
Finally, the WPW and the Long QT Syndromes can 
be responsible for hidden heart disease and sudden 
death. Patients with atrioventricular bypass tracts 
having very short refractory periods may be at risk of 
sudden death when atrial fibrillation develops, since 
the short refractory bypass tract may allow the 
conduction of three to four hundred impulses to the 
ventricle causing ventricular fibrillation. Obviously, 
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resting electrocardiograms are done infrequently in 
otherwise healthy individuals and this condition will 
prove difficult to diagnose. If an E K G pattern con-
sistent with WPW or the Long Q T Syndrome is seen, 
cardiovascular referral is recommended. 
A great deal of emphasis in the cardiology liter-
ature in the last few years has been directed towards 
the syndrome of Silent Myocardial Ischemia. It is 
now clear that as many as 80% of all episodes of 
myocardial ischemia are silent and not appreciated 
by the patient. Whether this is due to defective neural 
pathways, a crit ically small mass of ischemic myo-
cardium not leading to sufficient stimulation of pain 
fibers, or some as yet unrecognized factors is unclear, 
but the fact that the syndrome exists and is cl inical ly 
important has now been verified in multiple studies. 
Using objective techniques such as myocardial per-
fusion imaging, regional wall motion studies, and the 
measurement of lactat production by the myocardium, 
it is now clear that significant and even life threaten-
ing myocardial ischemia may exist without sympt-
omatology. Clearly in patients with known coronary 
disease, silent ischemia is common. Fortunately this 
almost always responds nicely to treatment with 
either long acting nitrates, beta blockers, or calc ium 
antagonists. 
How is the practitioner to evaluate the postulated 
one to two million individuals in this country who are 
completely asympromatic with silent ischemia? I 
believe that the most reasonable approach is one 
which utilizes cardiac risk factors as a preliminary 
screening technique for further evaluation. I have 
listed below what I consider to be the major risk 
factors for development of coronary disease in our 
population, and I would recommend that any indi-
vidual over the age 35 with two or more of these risk 
factors undergo multistage exercise testing. 
• Male Sex 
• Family History of Premature Coronary Heart 
Disease (Definite Ml or Sudden Death Before Age 
55 in a Parent or Sibl ing) 
• Cigarette Smoking 
• Low HDL Cholesterol Concentration ( < 3 5 mg/dl) 
• Diabetes Mellitus 
• Hypertension 
• Presence of Cerebrovascular or Peripheral Artery 
Disease 
• Sever Obesity (More Than 30% Overweight) 
While this may appear to be a huge and costly 
undertaking, it is clear to me that the state of the art 
in cardiovascular medicine is clearly moving in this 
direction as we begin to appreciate the magnitude of 
the silent ischemia problem. In fact, there have been 
several lawsuits filed by relatives of patients suffering 
sudden cardiac death who had previously visited 
their physicians with multiple coronary risk factors 
and not been stress tested. Thus , cardiologists are 
recommending stress testing for all individuals over 
the age of 35 with two or more coronary risk factors 
as outlined above. If the stress test is completely 
within normal limits, further evaluation is not neces-
sary. What, however, does one do with a stress test 
which shows significant S T depression in the absence 
of symptoms, and furthermore what is the appropriate 
next step in patients with borderline or equivocal 
studies? 
It now appears that radionuclide testing either with 
thalium 201, or gated blood pool imaging with tech-
netium pyrophosphate is the next appropriate diag-
nostic step in the subgroup of patients with multiple 
coronary risk factors and positive or equivocal stress 
findings. Patients whose radionuclide studies are 
positive should be referred for coronary angiography, 
but if the nuclear studies are negative, risk factor 
control and close clinical observation would be most 
appropriate. 
What about ambulatory electrocardiographic re-
cording with S T segment monitoring in the manage-
ment of such patients? It is my feeling that this is 
basical ly a research tool at present which has been 
to be shown of value only in assess ing patients with 
known coronary disease. Thus ambulatory holter 
type recordings are not of particular value in the 
screening of individuals for silent coronary disease 
or for the management of the average patient with 
this condition. Th is I believe is true because the 
ischemia detected in patients by ambulatory E K G 
monitoring is almost always detected on exercise 
stress testing. In fact, it is almost always the case that 
the only patients who have frequent and prolonged 
episodes of ischemia during ambulatory monitoring 
have ischemia induced at low levels of exercise during 
stress testing; patients with no ischemia changes 
during exerc ise or ischemia only at high levels of 
exerc ise rarely have silent ischemia during ambula-
tory monitoring. Thus the routine use of ambulatory 
E K G monitoring to document the presence of myo-
cardial ischemia in patients with chronic stable angina 
provides little additional information beyond that 
derived from stress testing. 
Nonetheless, we should not take ischemia lightly in 
patients with coronary disease. Clearly, the presence 
of ischemia is a negative prognostic factor in these 
patients. Effective pharmacologic and revascular iza-
tion strategies now exist to render all our patients 
with silent or overt coronary disease ischemia free. 
In summary, hidden heart d isease continues to be 
a cl inical challenge. If symptoms suggestive of myo-
cardial ischemia (such as chest pain or heaviness, 
undue breathlessness with exerc ise, or any anginal 
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equivalent type symptoms) are present then multi-
stage exercise testing is appropriate. As mentioned 
above, patients over the age of 35 with two or more 
coronary risk factors should undergo stress testing, 
with nuclear studies either of the perfusion or gated 
blood pool type reserved for those with positive or 
equivocal studies. Echocardiography should be util-
ized in patients with histories and physical examin-
ations consistent with hypertrophic cardiomyopathy, 
valvular heart disease or the Marfan's Syndrome. 
Cardiology and possibly electrophysiologic referral 
is important in patients suspected of having WPW or 
the Long Q T Syndrome. Myocardial ischemia, if 
detected, should be treated aggressively with aspir in, 
long acting nitrates, calcium blockers and beta block-
ers to minimize long term morbidity and mortality in 
this condition. 
* James A. Sbarbaro, M.D., F.A.C.C. received his 
M.D. degree at the University of Pennsylvania. 
He is Clinical Instructor in Medicine at the 
University of Colorado Health Sciences Center, 
Denver, Colorado. A member of the American 
College of Physicians, a Fellow of the American 
College of Cardiology, he is also a Diplomate in 
Internal Medicine and Cardiovascular Disease, 
American Board of Internal Medicine. 
HONESTY, Are We Really 
Totally honest? 
Every one of us takes pride in being honest and 
having a reputation as an honest person. We have more 
respect for our 'honest' colleagues and associates and 
our children. But is this 100%? Have you ever compli-
mented someone on an accomplishment or a new 
article of clothing just to avoid hurting someone's 
feelings, even though you really did not think a compli-
ment was deserved? Have you ever added or subtracted 
a little from the actual when asked about your age or 
height or weight or speed or car mileage? Surely most 
of us have at some time or another given in to such 
temptations with the rationalizations that it really didn't 
matter. Compromise a little when "it wouldn't hurt 
anyone or anything." But this is not true, for it hurts the 
individual. Any misrepresentation can make the next a 
little easier, so where do we draw the line? How many 
parents have asked children to help watch for law 
enforcement officers when driving a little faster than the 
speed limit? After a few years these same parents fuss 
at the same children when the child "drives a little too 
fast." We need not go out of our way to be brutally blunt 
hurting others, but sometimes it is really better to say 
nothing. I often tell my patients and their families that I 
will not hide the truth from them concerning their 
health, no matter how unpleasant the results may be. 
Once any person, and more especially a patient, learns 
they have been given untrue information, they can 
never again trust the person as totally and completely 
as before. Initially, almost all of us tend to believe any 
person with whom we come in contact until or unless 
something is found untrue. Next we may overreact and 
tend to distrust almost everyone. Such distrust may be 
channeled toward a sex, an age group, a religious 
group, an ethnic group, or others. Not that such is 
justified, but we felt put upon or our feelings were hurt. 
All of us are very familiar with the way our laws or rules 
change. This makes us suspicious of our governmental 
representatives and those of nations other than our 
own. Peace and progress are NOT built on distrust. 
Regardless of past experiences, we must become more 
trusting and also more trustworthy and honest. As we 
look ahead to meeting with our colleagues and members 
from many nations, let us work together in honest 
harmony. 
M. Young Stokes III, M.D. 
President, CAMA 
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